Clinical Trial

Lipiodol Prior to FET (LIFE)

Study acronym: LIFE
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 21, 2024 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
Lipiodol® flushing is an effective fertility treatment for women with unexplained infertility. It is speculated that the treatment effect could work through a direct effect of Lipiodol® on the endometrium. Given this direct effect on the endometrium, it is further hypothesized that Lipiodol® uterine treatment prior to In Vitro Fertilization (IVF)/ Intracytoplasmic Sperm Injection (ICSI) may also improve pregnancy rates. However, the effectiveness of Lipiodol® as an adjunct to IVF/ICSI treatment has not previously been examined in a well-powered and properly conducted randomised clinical trial.
Trial Details
NCT Number NCT06563908
Lead Sponsor Mỹ Đức Hospital
Collaborators: Guerbet
Conditions IVF, Frozen Embryo Transfer, Hysterosalpingography
Enrollment 784 participants
Start Date 2024-08-10
Primary Completion 2026-03 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-08-21